Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.48 USD | -2.26% | -1.05% | -20.07% |
May. 10 | UBS Cuts Price Target on Arrowhead Pharmaceuticals to $71 From $75, Keeps Buy Rating | MT |
May. 09 | Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.07% | 3.11B | |
+7.34% | 113B | |
+10.94% | 106B | |
+0.35% | 22.27B | |
-12.08% | 22.22B | |
-6.03% | 19.43B | |
-37.85% | 17.87B | |
-6.07% | 17.24B | |
+6.82% | 14.29B | |
+34.86% | 12.52B |
- Stock Market
- Equities
- ARWR Stock
- News Arrowhead Pharmaceuticals, Inc.
- Transcript : Arrowhead Pharmaceuticals, Inc. - Special Call